Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Locust Walk set for record high on $65.9 mln SPAC merger vote

** Shares of blank-check company  LWAC.O  rise 28.3%
premarket and are set to touch a record high of $11.24 at the
open
    ** LWAC says the majority of its stockholders voted in favor
of a proposed buyout of cancer biotech eFFECTOR Therapeutics
 urn:newsml:reuters.com:*:nGNX1mQ7vT
    ** Co says the deal, which was first proposed in May, will
provide total cash proceeds of about $65.9 mln, including ~$60
mln from PIPE funding  urn:newsml:reuters.com:*:nGNX3T48zz
    ** LWAC said deal is expected to close on or around
Wednesday; combined co will begin trading stock and warrants on
Nasdaq under ticker symbols "EFTR" and "EFTRW" from around
Thursday
    ** Up to Tuesday's close, LWAC is down 12.4% from its IPO
price of $10 in February

 (Reporting by Ruhi Soni in Bengaluru;)
 ((Ruhi.Soni@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news